How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment-Reference-Cited by-同舟云学术

How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment

Published:2001-07-17 Issue:5 Volume:41 Page:1422-1426
ISSN:0095-2338
Container-title:Journal of Chemical Information and Computer Sciences
language:en
Short-container-title:J. Chem. Inf. Comput. Sci.

Author:

Wang Renxiao¹,Wang Shaomeng¹

Affiliation:

1. Institute of Cognitive and Computational Science and Lombardi Cancer Center, Departments of Oncology and Neuroscience, Georgetown University Medical Center, 4000 Reservoir Road, Washington, D.C. 20007

Publisher

American Chemical Society (ACS)

Subject

Computational Theory and Mathematics,Computer Science Applications,Information Systems,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci010025x

Reference16 articles.

1. Virtual screening—an overview

2. Drug Discovery: A Historical Perspective

3. A geometric approach to macromolecule-ligand interactions

4. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

5. Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building shape-focused pharmacophore models for effective docking screening;Journal of Cheminformatics;2024-08-09

2. CADD: - Exploring the Digital Frontier in Drug Designing;2024 3rd International Conference on Computational Modelling, Simulation and Optimization (ICCMSO);2024-06-14

3. Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for de novo drug design and computational chemistry approaches;2024-02-13

4. Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for de novo drug design and computational chemistry approaches;RSC Medicinal Chemistry;2024

5. Targeting Gpr52 for Potential Agonists for Schizophrenia Therapy: A Computational Drug Discovery Study;2024